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Abstract
Background: This study evaluated the effectiveness of treating pseudarthrosis in rats by using bone marrow cell
suspensions or cultures of bone marrow mesenchymal stromal cells
Methods: Thirty-eight specific pathogen-free (SPF) animals were randomly assigned to four groups: Group 1,
Control, without surgical intervention; Group 2 (Placebo), experimental model of femoral pseudarthrosis treated
only with saline solution; Group 3, experimental model of femoral pseudarthrosis treated with heterologous bone
marrow cells suspension; Group 4, experimental model of femoral pseudarthrosis treated with cultures of
heterologous mesenchymal stromal cells from bone marrow. When pseudarthrosis was confirmed by simple
radiological studies, digital radiography and histopathology after a 120-day postoperative period, Groups 2, 3 and 4
were treated as above. At 30, 60 and 90 days after the treatment, all animals were evaluated by simple radiological
studies, and at the end of the experiment, the animals were assessed by computed axial tomography and
anatomopathological and histomorphometric examinations.
Results: Injected cells were detected in the areas affected by pseudarthrosis using scintigraphy within the first 24
hours after their administration. After 60 days, the animals of Group 3 showed callus formation while the animals
of Group 4 presented periosteal reaction and had some consolidated areas. In contrast, Group 2 showed a
predominance of fibro-osteoid tissue. After 90 days, bone consolidation and remodeling was observed in all
animals from Group 3 whereas animals from Group 4 exhibited partial consolidation and those ones from Group 2
persisted with pseudarthrosis.
Conclusion: The treatment with heterologous bone marrow cells suspension proved to be effective in the
treatment of pseudarthrosis whereas cultures of heterologous bone marrow mesenchymal stromal cells did not
show the same potential to aid bone healing.
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Background
The term pseudarthrosis defines the nonunion of a frac-
ture when the bone repair process has ceased for any
reason. The lack of union of fractured bone surfaces in
such circumstances results from the presence of fibro-
cartilage or fibrous tissues between the bone extremities
[1]. Other factors that contribute to the persistence of
this problem are the instability of the fracture, the lack
of adequate blood supply and the presence of infection.
The fracture healing process usually begins from a
trauma that results in hematoma formation, followed by
inflammation, angiogenesis, cartilage formation, calcifi-
cation, and bone remodeling with the absorption of the
newly formed callus. The bone consolidation process
requires growth factors, mesenchymal stem cells (MSCs)
and cytokines [2].
To date, there is no optimal technique for the treat-
ment of pseudarthrosis; therefore, surgery is still the
best option [3]. However, cell therapy has become a
promising alternative because it is less invasive than sur-
gery. Thus, stem cells (SCs) have been tested in bone
diseases because of their capacity to self-renew and
* Correspondence: louiz_25@yahoo.com.br
1Post-graduate Program in Surgical Sciences, Department of Surgery, School
of Medicine, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil
Full list of author information is available at the end of the article
Ferreira et al. Journal of Translational Medicine 2012, 10:51
http://www.translational-medicine.com/content/10/1/51
© 2012 Ferreira et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.
generate differentiated cells to repair specific tissues
[4-6]. Among the various types of bone marrow cells,
adult mesenchymal stem cells (MSCs) have sparked
interest. Their multipotentiality and the techniques
available for their isolation and in vitro expansion have
validated the use of these cells as a therapeutic alterna-
tive with a broad spectrum of applications in cases of
bone fractures and chronic bone lesions [6,7].
The current study evaluated the efficacy of heterolo-
gous bone marrow cells suspension and cultures of het-
erologous bone marrow mesenchymal stromal cells in
the treatment of hypertrophic pseudarthrosis consider-
ing that both types of cells have the ability to generate a
new bone after in vivo transplantation. Cells suspension
has a heterogeneous population which contains all
lineages from the bone marrow including progenitor
and hematopoietic stem cells and also bone marrow
mesenchymal stromal cells. On the other hand cultures
of bone marrow stromal have cells with a stem-cell-like
character. It is still controversial whether bone marrow
stromal cells and so-called mesenchymal stem cells are
the same population [8].
Methods
This study was approved by the Ethics Committee for
the Use of Laboratory Animals in Research of the
School of Medicine of UFRJ, in accordance with the
Brazilian legislation and the NIH Guide for the Care
and Use of Laboratory Animals.
Animals
A total of 38 specific pathogen-free (SPF) male Rattus
norvegicus albinus, aged between four and six months
with an average weight of 250 g, were obtained from the
vivarium of the Experimental Surgery Center at the
School of Medicine of UFRJ. The animals were main-
tained at 25°C and under a photoperiod of 12 hours
(light/dark cycle). They were provided water and pellet
of balanced industrial food ad libitum.
Among the 38 experimental animals, 6 served as donor
of bone marrow cells. The other 32 animals were ran-
domly divided into four groups, each containing eight ani-
mals: Group 1 (Control), without operative procedures,
only observed during the experiment. Group 2 (Placebo),
in which pseudarthrosis was treated with saline solution;
Group 3, in which pseudarthrosis was treated with hetero-
logous bone marrow cell suspension; and Group 4, in
which pseudarthrosis was treated with cultures of hetero-
logous bone marrow mesenchymal stromal cells.
The same anesthetic mixture (10% ketamine,10 mg/kg
and 2% xylazine, 100 mg/kg) was administered intraperito-
neally before the two surgeries conducted for the produc-
tion of pseudarthrosis and the injection of saline solution
(Group 2) or bone marrow cells (Groups 3 and 4).
First surgical intervention
A model of pseudarthrosis previously designed by one of
the authors of this study was used [9]. This model con-
sisted of the following surgical steps: diaphyseal osteot-
omy of the left femur, interposition of a pedicled fascia
lata flap sutured to the distal portion of the semimem-
branosus muscle, transfixion of a 3-0 nylon wire in the
proximal and distal segments, bone alignment of the
two extremities with the aid of a knot tightened onto
the nylon wire and layered closures as the final step
(Figure 1).
After the 120-day postoperative period, in addition to
performing simple radiological studies (using the Helio-
dent 60B device, Siemens, 127 V-60 kV, 10 mA, 50-60
Hz, for 2 seconds), three animals from each group were
painlessly euthanized with an anesthetic overdose (4 ml
of 2.5% sodium pentothal delivered. intraperitoneally).
The area affected by pseudarthrosis was then removed
for analysis with a digital X-ray device (GE Silhouette®
model, 20 kV, 0.41 mA, for 180 seconds), followed by a
histopathological study with hematoxylin and eosin
stain.
Degree criterion of claudication assessment
The authors adapted some criterion of claudication,
generally used for dogs (Table 1), and classified them
according to 5 degrees of severity (from absence to
severe) [10].
Collection of cell suspensions and cultures of bone
marrow cells
Cells were collected from the femur and tibia of six
donor animals after underwent CO2-induced euthanasia.
The bones were then manually cleaned of muscle tissue
and treated for 30 minutes at 37°C with a 0.125% tryp-
sin solution and 1 mg/mL of collagenase IA (Sigma
Aldrich Co., St. Louis, MO, USA) to remove fibrous tis-
sue. Bone marrow collection was performed by section-
ing the epiphyseal regions and flushing the internal
cavities of the bones with culture medium using dispo-
sable syringes. The obtained cell suspension was filtered
through a nylon mesh with a porosity of 100 μm and
centrifuged at 1,500 rpm for 5 minutes. The cells were
resuspended in low glucose DMEM (Dulbecco’s Modi-
fied Essential Medium, Hyclone) and quantified in a
hemocytometer. The cell concentration was adjusted,
and 3 × 106 cells in 500 μL of DMEM, without fetal
bovine serum (FBS), were injected into animals with 1-
mL syringes. The remaining bone marrow cells,
obtained according to the above described procedure,
were distributed at a concentration of 1 × 106/mL in
culture flasks with 25 cm3 of low glucose DMEM con-
taining 15% FBS (Cultilab, Campinas, SP, Brazil) and
antibiotics (100 U/ml penicillin G sodium and 100 μg/
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mL streptomycin, Sigma Aldrich Co., St. Louis, MO,
USA) and incubated at 37°C with 5% CO2 for two or
three days. After this period, any nonadherent cells were
removed by washing the monolayer with phosphate-buf-
fered saline solution (PBS), and the culture medium was
replaced. Cells were maintained in culture until they
reached 70% confluence and expanded up to the third
passage. Cells were cryopreserved in liquid nitrogen at
-140°C until they were needed; at this time, they were
thawed in a 37°C water bath and centrifuged at 1,500
rpm for 5 minutes. Cell viability was determined using
the Trypan Blue Exclusion Test. Each animal received
injections of 3 × 106 cells in 500 μL of DMEM.
Second surgical intervention
To access the areas affected by pseudarthrosis in Groups
2, 3 and 4, a 5-cm long longitudinal incisions were made
in the diaphysis of the femur, which was dissected by
layer under strict hemostasis. The fibrous tissues found
on and around the fractured area were excised, and the
medullary canal of both extremities of the femur was
made permeable by making rotational movements with
a hypodermic needle (27 mm × 8 G). Animals in
Groups 3 and 4 received injections of cells suspension
and cultures of mesenchymal stromal cell, respectively,
that were extracted from bone marrow and marked with
technetium-99 m radionucleotide (using the protocol of
the Laboratory of Cell and Molecular Marking of the
Department of Radiology and Nuclear Medicine of Hos-
pital Universitário Clementino Fraga Filho - UFRJ) [11].
These injections occurred in and around the medullary
canals of fracture segments. The same procedure was
conducted in Group 2, but with the administration of
saline solution into the medullary canal.
The fracture was stabilized with the introduction of a
flat intramedullary pin that occupied 50 to 60% of the
diameter of the medullary canal. The surgery was con-
cluded with muscle and skin closures.
Figure 1 Fascia lata (narrow arrow) interpositioned between the aligned bone segments and tied with nylon 3-0 wire (large arrow).
Table 1 Classifications of claudication
Degree Criterion
1 Absence of claudication, full limb support when the animal was in a standing position or during physical activities.
2 Mild claudication after exercise or prolonged decumbency.
3 Sporadic claudication when walking or running and weight relief on the operated limb, even in a standing position.
4 Constant claudication when walking and lack of limb support when running; incomplete support in the orthostatic position.
5 Full or absent support during physical activities or in a standing position.
Source: Adapted from Muzzi (2003)
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At 30, 60 and 90 days after the second intervention,
the degree of claudication was assessed, and the animals
were classified according to the increasing scale of grav-
ity [9] (Table 1).
At the same time points, all animals of Groups 3 and
4 (bone marrow cells treatments) and Group 2 (placebo)
were submitted to an X-ray examination. All animals
also underwent a CT scan (NewTom 3 G, QR, Italy, 100
μSv) 90 days after the second surgery. The images were
captured with NNT software and analyzed with Dental
Slice software to observe the line of calcification
throughout each sagittal incision.
Samples of the left femur and the tissues surrounding
the affected areas of pseudarthrosis were collected for his-
topathological analysis. The material was fixed in 10% buf-
fered formalin, decalcified with Allkimia® and routinely
processed for paraffin embedding. The histological sam-
ples obtained were stained with hematoxylin and eosin
(HE) stain and evaluated using the 10× objective of a
Leica® DM5000 B binocular optical microscope. A digital
camera attached to the microscope was used to sequen-
tially capture images (10 per slide). Photomicrographs
were analyzed using Image Pro Plus ® 4.5 software (Media
Cybernetics) to quantify at histomorphometry the percen-
tages fibrous tissue of each sample.
Statistical analysis
For the claudication results, the Mann-Whitney U-test
was applied. To analyze the histomorphometric data,
the nonparametric Kruskal Wallis test was applied, fol-
lowed by the Dunn’s test, with the aid of the GraphPad
InStat® (v. 3.01) software. The results were considered
significant for all p-values under 0.05.
Results
In all animals, except Group 1, claudication reached its
maximum level (with an average score of 5) after the
first surgery, and this maximum level was maintained
for 30 days after the second surgery. Ninety days after
the injection of bone marrow cells, a slight amount of
claudication was observed in Group 3 (grade 2), whereas
in Group 4, it was worse with a constant level of claudi-
cation including both the absence of limb support to
run and incomplete limb support in the standing posi-
tion (grade 3). Group 2 maintained a high degree (grade
4) of claudication. Results in Group 3 were significantly
different than Groups 2 and 4 (p < 0.05).
Plain and digital radiographies performed 120 days
after the first surgery revealed pseudarthrosis formation
as a result of the model used in rats of Groups 2, 3 and
4 (Figure 2). In Groups 3 and 4, twenty-four hours after
treatment, scintigraphies showed an uptake of bone
marrow mononuclear cells in the area of pseudarthrosis
(Figure 3).
In the plain radiological study of the femurs from ani-
mals in Groups 2 and 4 performed 30 days after the sec-
ond surgery, no calcification was detected between the
fractured segments. At the same time point, animals
from Group 3 showed early calcification. After 60 days,
callus formation was detected in Group 3, whereas in
Group 4, there was an intense periosteal reaction with
some consolidated areas. At 90 days after surgery,
Group 3 animals exhibited bone remodeling and callus
absorption, whereas the Group 4 results did not differ
from the results observed at 60 days. In Group 2 ani-
mals, no bone consolidation was observed throughout
the study (Figure 4).
For Group 2, the computed tomography images made
on the sagittal incisions, 90 days after the second sur-
gery, showed an absence of bone halo, unlike Group 3,
in which there was complete bone consolidation repre-
sented by a halo around the entire bone surface in the
previously fractured region (Figure 5). In Group 4 speci-
mens, the halo was incomplete.
The histopathological results obtained 120 days after
the first surgery demonstrated the absence of bone con-
solidation in all animals. Ninety days after the second
surgery, an absence of bone was observed in Group 2,
Figure 2 Plain radiography (A) and digital radiography (B) of the femur of a rat specimen. The white arrows indicate the formation of
pseudarthrosis 120 days after the first surgery. This result was found for all animals in Groups 2, 3 and 4.
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Figure 3 Scintigraphic image captured at 24 hours (Groups 3 and 4) after the stem cells treatment and the outline of a rat. Note the
whitish area with a red halo that delineates the concentration of bone marrow mesenchymal cells in this area.
Figure 4 Plain film of the femur 90 days after the injection of saline solution (Group 2, placebo) or stem cells (Groups 3 and 4). The
absence of bone consolidation in Group 2 rats (A) was verified. Group 4 animals (B) had periosteal reactions (yellow arrows) but did not have
bone calluses (white arrow). In Group 3 (C), bone remodeling with callus absorption (arrow) was observed.
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bone remodeling was observed in Group 3 and partial
bone consolidation interspersed with a significant
amount of cartilage was detected in Group 4 (Figure 6).
The histomorphometric analyses revealed an increase in
the fibrotic area in Group 2 as compared with Group 3
90 days after the second surgery (Figure 7).
Discussion
Traumas that result in bone fractures trigger a repair
process that is highly associated with osteoblast prolif-
eration and substances inhibit the fracture-induced
inflammatory process. As a result of this inflammation,
there is active mitochondrial oxygen consumption and
the production of reactive oxygen species [12]. Under
these circumstances, viable osteoprogenitor cells must
be present to allow for the production of an extracellu-
lar matrix at each stage of bone repair [13].
The mechanism of bone remodeling is not clear, and
there is lack of consensus in the literature. The osteo-
genic lineage, which includes both osteoblasts and
chondroblasts, is derived from a stromal stem cell in the
postnatal organism [14]. However, studies indicate that
agents that induce osteoclasts are necessary to allow this
process to occur in the proper manner [15].
Several methods have been used to treat pseudarthrosis:
decortication or osteoperiosteal scaling, cancellous auto-
grafting, the addition of bone morphogenetic protein, pla-
telet growth factors, callus distraction with external
fixators, vascularized bone graft filling, internal stabiliza-
tion materials (a compression plate, pin or locked reamed
intramedullary nailing), external stabilizers (orthotics or
external fixators), ultrasound, shock waves and electro-
magnetic fields [16-20]. This plethora of options indicates
a lack of consensus on the best method to treat pseudar-
throsis and results in unfitness for work and deformities in
those patients who experience pseudarthrosis, causing
heavy psychosocial and economic burdens for families and
overcrowding in public health stations.
Within the scope of experimental studies, it is very
difficult to reproduce pseudarthrosis bone structures in
Figure 5 Tomographic image of a sagittal section of a femur 90 days after the second surgery. A pseudo-halo formation was detected in
Group 4 animals (A), the consolidation of which was partial; in turn, Group 3 rats (B) had full-halo consolidation around the intramedullary pin,
which represents bone consolidation.
Figure 6 Histological preparations 90 days after the second surgery, HE, using a 10× objective and the scale bar is 100 μm, in groups
2, 3 and 4. G = Groups, NU = nonunion area, CT = cartilage, B = bone. M = medulla. There was no bone consolidation in Group 2. In Group 3,
almost all of the fractured area was filled with bone, with a small area of cartilage interposed. In Group 4, there was partial bone consolidation,
with a significant amount of cartilage in the fracture line.
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laboratory animals because the models are generally
accompanied by significant injuries in surrounding tis-
sues and in the bone itself [21,22], creating biases in the
interpretation of results. SPF Wistar rats were chosen
because of their small size and easy handling, which also
applies to the use of intramuscular anesthesia; the exis-
tence of a bony structure covered with a large muscle
mass in the hind limbs, which is comparable to that of
human species; and their reduced susceptibility to
infection.
A reliable model of hypertrophic pseudarthrosis in
animals that was previously developed by the authors
was able to mimic the conditions found in human
beings [9,23]. Pseudarthrosis was detected in all animals
within an acceptable period, without the presence of
infectious foci. The simple bone section without fracture
reduction is not itself sufficient to prevent spontaneous
recovery because there may be calcification even in the
presence of a misalignment in the bone axis [24]. Given
this possibility, the interpositioning of a pedicled fasciae
lata muscle flap was an essential step to ensure success
in obtaining nonunion bone in all cases. Regarding this
matter, no similar descriptions for such surgical techni-
que were found in the literature.
There are other models designed for small and med-
ium-sized animals that reproduce pseudarthrosis, but
these models involve the immediate treatment of frac-
tures with the placement of fasteners; also, some are dif-
ficult to manufacture, expensive and require the
eventual removal of bone segments of different lengths
to artificially create a gap [24-29]. Sometimes such mod-
els also holds for the cauterization or resectioning of the
periosteum [29]. The application of these models to
humans is limited because the mechanism of injury
often creates conditions that are different from these
that occur after a trauma. Furthermore, the areas of
fracture are immediately immobilized without generat-
ing instability and without the interpositioning of fibro-
cartilaginous tissues in the initial phase of the healing
process.
Indeed, in all animals of Groups 2, 3 and 4, the clini-
cal evaluations showed severe claudication and also the
histopathological examinations detected the presence of
fibro-osteoid tissue 120 days after the first surgery, indi-
cating pseudarthrosis. As observed by other authors, the
most significant findings were the absence of endochon-
dral ossification, the prolapse of soft tissue parts and the
closure of the medullary canal [26-28]. These character-
istics were also detected in plain and digital radiological
studies, with the presence of hypertrophic pseudarthro-
sis in all of the animals subjected to femoral fractures.
Cell therapy has generated a great interest in the
design of animal models intended to investigate new
options for the treatment of pseudarthrosis. Recently,
studies have shown that multipotent stem cells can dif-
ferentiate into lineages other than those of the tissue of
origin [30-32]. As of yet, the risks of treatment with
stem cells are poorly understood (e.g., disease transmis-
sion, neoplasia formation, immune responses with rejec-
tion, nidation in unexpected in places, atypical features);
therefore, a priori studies with animal models are essen-
tial [33].
Mesenchymal stem cells (MSCs) are a population of
adult cells firstly described in the bone marrow. From a
Figure 7 The percentages of fibrous tissue formed 90 days after the injection of stem cells or placebo. There was less fibrosis in the
group (G) that received a suspension of bone marrow cells (G3) as compared with Group 2 (G2, placebo). * G2 vs. G3 = p < 0.05.
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physiological point of view, the differentiation of MSCs
into osteoblasts is fundamental for the organization and
repair of bone tissues [31]. Most clinical trials involving
stem cell therapy have used mesenchymal cells derived
from bone marrow [33].
The presence of cellular elements of bone marrow,
including vascular growth factors, is important in pro-
moting angiogenesis and essential for bone regeneration
[34,35]. Tissue revascularization facilitates the transfor-
mation of pluripotent cells into osteoblasts and those
cells that cross the fracture lines enable primary Haver-
sian remodeling [5,18,36]. For this reason, care was
taken not only to revive the edges of the wound by
removing fibrotic tissues in and around the area of
pseudarthrosis but also to recanalize the medullary
region, leaving about 50 to 60% of the diameter of this
canal free.
The recovery of functional osteoblasts from MSCs is a
widely used technique in tissue engineering and cell
therapy. A study conducted by Iida and colleagues invol-
ving more than 300 rats and the use of in vitro autolo-
gous mesenchymal cultures for bone reconstruction
after surgical excision revealed that MSCs have an
osteogenic potential [37].
The vast majority of studies involving mesenchymal
stem cells are performed in vitro. Although the biology
of these cells in culture is fairly well known, the same is
not true for fractured bones under in vivo conditions
[38,39].
MSCs can be grown in in vitro cultures and differen-
tiated into osteocytes, chondrocytes or other cells [40].
To achieve good quality regenerative processes, at least 2
× 106 cells must be transplanted, which can be accom-
plished without the need for culturing MSCs [40,41].
However, other studies on bone regeneration argue that
osteogenesis can be benefited by techniques that concen-
trate osteoprogenitor cells [42]. Osteoprogenitor cells
derived from the mesoderm and mesenchymal cells have
a mitotic capacity and produce growth factors. The use
of cultures enables replication with long-term cell main-
tenance. In Group 3 it was injected bone marrow cells
suspension containing a pool of hematopoietic and non-
hematopoietic lineage including stem cells and mesench-
ymal stromal cells. Adult stem cells are rare and nearly 1
in 10,000 to 15,000 cells in the bone marrow is a hemato-
poietic stem cell [43]. In Group 4 bone marrow mesench-
ymal stromal cells was implanted but it is not clear if
such stromal cells could be classified as stem cells or pro-
genitor cells. In fact to characterize the cellular lineage in
vitro, a population of pure stem cells from bone marrow
should be isolated and a reproductive cloning and expan-
sion should be done in culture dishes to induce the dif-
ferentiation of bone marrow stromal cells to osteoblastic
lineage. However it has been described at clonal level, a
progressive loss of stem features with increasing popula-
tion doubling in culture [7].
The associations among mesenchymal cells, bone
morphogenetic proteins and growth factors seem to
favor their use in the treatment of hard-healing bones
[30]. Seeking to prevent bias in the interpretation of
results, the use of osteoinductive substances such as
bone morphogenetic proteins was avoided because our
focus was the therapeutic potential of mesenchymal
stem cells.
Bone marrow cells suspension are considered the best
choice because, compared with cultures of bone marrow
mesenchymal stromal cells, that procedure is more cost
effective, can be more easily accomplished and requires
less time and less technical instrumentation [41].
Despite the use of heterologous cells in this experiment,
there was no need for any prior immunosuppressive
therapy. No sign of severe acute or chronic inflamma-
tion was observed in animals injected with bone marrow
cell suspensions. Besides, no mononuclear infiltration
that is characteristic of chronic immune-mediated
inflammation was observed in histopathological sections.
In general, the systemic vascular compartment is tar-
geted in the administration of stem cells for therapeutic
purposes [30]. These cells have chemotactic migratory
abilities to travel to injured areas; in addition, these cells
settle in the impaired areas. This feature is known as
homing [12]. Nevertheless, many of these cells are initi-
ally retained in the lung and the liver [30]. Thus, we
administered the bone marrow cells directly into the
lesion after the surgical release of fibrosis and medullary
recanalization. The location of such cells was confirmed
by scintigraphic examinations.
In Group 3, there was bone consolidation within 60
days after the administration of bone marrow cells sus-
pension. This result was also partially observed within 90
days in Group 4 animals, which were treated with cul-
tures of stromal cells, and there was an intense periosteal
reaction. Clinical examinations, imaging studies and his-
tomorphometric analyses confirmed these findings
endorsing the best efficacy of the cells in suspension.
In a fracture pseudarthrosis model involving rats,
Nakamura and colleagues conducted a therapeutic study
of the effect of the transplantation of a single layer of
bone marrow cells cultured in a medium containing
dexamethasone and ascorbic acid phosphate. Radio-
graphs and histological analyses were performed at 2, 4
and 8 weeks, while ultrasound and biomechanical ana-
lyses were performed eight weeks postoperatively. In the
group with stromal cells, radiographs and histological
sections demonstrated the formation of callus areas
around the fracture site. In contrast, the control group,
which did not receive the transplantation, exhibited
pseudarthrosis of the femur. These authors concluded
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that cell transplantation in a single layer may contribute
to the reconstruction of bone tissues in cases of pseu-
darthrosis, bone defects and osteonecrosis [32]. Our
study examined a greater interval, 12 weeks after the
administration of bone marrow cells suspension stimu-
lated complete bone healing in rats with hypertrophic
pseudarthrosis, whereas cultures of bone marrow
mesenchymal stromal cells were less effective. The bio-
mechanical analyses of animals in Group 3 indicated a
significant and early recovery with regard to the walking
capacity of rats.
Considering the high socioeconomic costs resulting
from the inability to work, the development of disabil-
ities that result from pseudarthrosis, and the lack of
consensus regarding the best treatment of pseudarthro-
sis, bone marrow cells suspension therapy seems to be a
promising option. Further studies that examine the
administration of these cells by less invasive means or
even with a specific lineage of stem cells expanded in
cultures are needed for the purpose of delineating their
therapeutic applicability in pseudarthrosis in human
beings to achieve more favorable treatment outcomes.
Conclusions
Bone marrow cells suspension appear to be more effec-
tive in the treatment of pseudarthrosis than cultures of
bone marrow mesenchymal stromal cells because they
seemingly contribute to the successful bone remodeling
and reduce recovery times.
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